跳至主要内容
临床试验/EUCTR2014-003422-41-FI
EUCTR2014-003422-41-FI进行中(未招募)1 期

The effects of PXR activation on hepatic fat content - Rifa-Stea

Oulu University Hospital, Department of Internal Medicine0 个研究点目标入组 16 人开始时间: 2014年10月1日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Healthy volunteers
  • 18-40 years of age
  • Body mass index (BMI) 18.5-25 kg/m2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 16
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Systolic blood pressure over 150 mmHg
  • Any continuous medication (hormonal intrauterine device is
  • Any significant medical condition
  • Insensitivity to rifampicin
  • Pregnancy and lactation
  • Previous difficult venipuncture
  • Alcohol and medicine abuse and drug use
  • Participation to any other pharmaceutical trial within on month of
  • Claustrophobia
  • Metal and other implants which are contraindications to MRI

研究者

发起方
Oulu University Hospital, Department of Internal Medicine

相似试验